Key issues in addressing the comorbidity of attention deficit hyperactivity disorder and pediatric epilepsy

Epilepsy and Behavior

Volumn 37, Issue , 2014, Pages 310-315

  Salpekar, Jay A ^a   Mishra, Gaurav ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

ADHD; Diagnosis; Epilepsy; Pediatrics; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; PHENOBARBITAL; PSYCHOSTIMULANT AGENT; TOPIRAMATE; ANTICONVULSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS;

ANTICONVULSANT THERAPY; ATTENTION; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BENIGN CHILDHOOD EPILEPSY; CHILD SAFETY; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DROWSINESS; DRUG SAFETY; HUMAN; MEDICAL HISTORY; MENTAL CONCENTRATION; PATIENT CARE; PATIENT SAFETY; REVIEW; SEIZURE THRESHOLD; TREATMENT OUTCOME; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; EPILEPSY; FEMALE; HUMANS; PEDIATRICS; PSYCHOLOGY; QUALITY OF LIFE;

ANTICONVULSANTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMORBIDITY; EPILEPSY; FEMALE; HUMANS; PEDIATRICS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84907052511     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.04.021     Document Type: Review

References (69)

1. Plioplys S., Dunn D.W., Caplan R. 10-year research update review: psychiatric problems in children with epilepsy. J Am Acad Child Adolesc Psychiatry 2007, 46:1389-1402.
2. Dunn D.W., Austin J.K. Differential diagnosis and treatment of psychiatric disorders in children and adolescents with epilepsy. Epilepsy Behav 2004, 5(Suppl. 3):S10-S17.
3. Goldman L.S., Genel M., Bezman R.J., Slanetz P.J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1998, 279:1100-1107.
4. Faraone S.V., Sergeant J., Gillberg C., Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2003, 2:104-113.
5. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007, 164:942-948.
6. Cohen R., Senecky Y., Shuper A., Inbar D., Chodick G., Shalev V., et al. Prevalence of epilepsy and attention-deficit hyperactivity (ADHD) disorder: a population-based study. J Child Neurol 2013, 28:120-123.
7. Dunn D.W., Austin J.K., Harezlak J., Ambrosius W.T. ADHD and epilepsy in childhood. Dev Med Child Neurol 2003, 45:50-54.
8. Gonzalez-Heydrich J., Dodds A., Whitney J., Macmillan C., Waber D., Faraone S.V., et al. Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav 2007, 10:384-388.
9. Socanski D., Aurlien D., Herigstad A., Thomsen P.H., Larsen T.K. Epilepsy in a large cohort of children diagnosed with attention deficit/hyperactivity disorders (ADHD). Seizure 2013, 22:651-655.
10. Hermann B., Jones J., Dabbs K., Allen C.A., Sheth R., Fine J., et al. The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy. Brain 2007, 130:3135-3148.
11. Hesdorffer D.C., Ludvigsson P., Olafsson E., Gudmundsson G., Kjartansson O., Hauser W.A. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004, 61:731-736.
12. Cerminara C., D'Agati E., Casarelli L., Kaunzinger I., Lange K.W., Pitzianti M., et al. Attention impairment in childhood absence epilepsy: an impulsivity problem?. Epilepsy Behav 2013, 27:337-341.
13. Kaufmann R., Goldberg-Stern H., Shuper A. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. J Child Neurol 2009, 24:727-733.
14. Purper-Ouakil D., Ramoz N., Lepagnol-Bestel A.M., Gorwood P., Simonneau M. Neurobiology of attention deficit/hyperactivity disorder. Pediatr Res 2011, 69:69R-76R.
15. Gonzalez-Heydrich J., Hamoda H.M., Luna L., Rao S., McClendon J., Rotella P., et al. Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy. Neuropsychiatry 2012, 2:385-391.
16. Bechtel N., Kobel M., Penner I.K., Specht K., Klarhofer M., Scheffler K., et al. Attention-deficit/hyperactivity disorder in childhood epilepsy: a neuropsychological and functional imaging study. Epilepsia 2012, 53:325-333.
17. Killory B.D., Bai X., Negishi M., Vega C., Spann M.N., Vestal M., et al. Impaired attention and network connectivity in childhood absence epilepsy. Neuroimage 2011, 56:2209-2217.
18. Loo S.K., Makeig S. Clinical utility of EEG in attention-deficit/hyperactivity disorder: a research update. Neurotherapeutics 2012, 9:569-587.
19. Holtmann M., Becker K., Kentner-Figura B., Schmidt M.H. Increased frequency of rolandic spikes in ADHD children. Epilepsia 2003, 44:1241-1244.
20. Becker K., Sinzig J.K., Holtmann M. Attention deficits and subclinical epileptiform discharges: are EEG diagnostics in ADHD optional or essential?. Dev Med Child Neurol 2004, 46:431-432.
21. Richer L.P., Shevell M.I., Rosenblatt B.R. Epileptiform abnormalities in children with attention-deficit-hyperactivity disorder. Pediatr Neurol 2002, 26:125-129.
22. Hughes J.R., DeLeo A.J., Melyn M.A. The electroencephalogram in attention deficit-hyperactivity disorder: emphasis on epileptiform discharges. Epilepsy Behav 2000, 1:271-277.
23. Wannag E., Eriksson A.S., Larsson P.G. Attention-deficit hyperactivity disorder and nocturnal epileptiform activity in children with epilepsy admitted to a national epilepsy center. Epilepsy Behav 2010, 18:445-449.
24. Silvestri R., Gagliano A., Calarese T., Arico I., Cedro C., Condurso R., et al. Ictal and interictal EEG abnormalities in ADHD children recorded over night by video-polysomnography. Epilepsy Res 2007, 75:130-137.
25. Shi Z., Zhou A., Liu P., Zhang P., Han W. An EEG study on the effect of self-relevant possessive pronoun: self-referential content and first-person perspective. Neurosci Lett 2011, 494:174-179.
26. Hale T.S., Smalley S.L., Dang J., Hanada G., Macion J., McCracken J.T., et al. ADHD familial loading and abnormal EEG alpha asymmetry in children with ADHD. J Psychiatr Res 2010, 44:605-615.
27. Snyder S.M., Quintana H., Sexson S.B., Knott P., Haque A.F., Reynolds D.A. Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample. Psychiatry Res 2008, 159:346-358.
28. Aarts J.H., Binnie C.D., Smit A.M., Wilkins A.J. Selective cognitive impairment during focal and generalized epileptiform EEG activity. Brain 1984, 107(Pt 1):293-308.
29. Binnie C.D., Channon S., Marston D.L. Behavioral correlates of interictal spikes. Adv Neurol 1991, 55:113-126.
30. Sherman E.M., Slick D.J., Connolly M.B., Eyrl K.L. ADHD, neurological correlates and health-related quality of life in severe pediatric epilepsy. Epilepsia 2011, 48(6):1083-1091.
31. Parisi P., Bruni O., Pia Villa M., Verrotti A., Miano S., Luchetti A., et al. The relationship between sleep and epilepsy: the effect on cognitive functioning in children. Dev Med Child Neurol 2010, 52:805-810.
32. Chan S., Baldeweg T., Cross J.H. A role for sleep disruption in cognitive impairment in children with epilepsy. Epilepsy Behav 2011, 20:435-440.
33. Aldenkamp A., van Bronswijk K., Braken M., Diepman L.A., Verwey L.E., van den Wittenboer G. A clinical comparative study evaluating the effect of epilepsy versus ADHD on timed cognitive tasks in children. Child Neuropsychol 2000, 6:209-217.
34. Vega C., Vestal M., DeSalvo M., Berman R., Chung M., Blumenfeld H., et al. Differentiation of attention-related problems in childhood absence epilepsy. Epilepsy Behav 2010, 19:82-85.
35. Berman R., Negishi M., Vestal M., Spann M., Chung M.H., Bai X., et al. fMRI, and behavior in typical childhood absence seizures. Epilepsia 2010, 51:2011-2022.
36. Williams J., Griebel M.L., Sharp G.B., Lange B., Phillips T., Delosreyes E., et al. Differentiating between seizures and attention deficit hyperactivity disorder (ADHD) in a pediatric population. Clin Pediatr (Phila) 2002, 41:565-568.
37. Salpekar J.A., Dunn D.W. Psychiatric and psychosocial consequences of pediatric epilepsy. Semin Pediatr Neurol 2007, 14:181-188.
38. Goldberg J.F., Burdick K.E. Cognitive side effects of anticonvulsants. J Clin Psychiatry 2001, 62(Suppl. 14):27-33.
39. Caplan R. Psychopathology in pediatric epilepsy: role of antiepileptic drugs. Front Neurol 2012, 3:163.
40. Mitchell W.G., Zhou Y., Chavez J.M., Guzman B.L. Effects of antiepileptic drugs on reaction time, attention, and impulsivity in children. Pediatrics 1993, 91:101-105.
41. Bourgeois B.F. Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy. J Child Neurol 2004, 19(Suppl. 1):S15-S24.
42. Sommer B.R., Mitchell E.L., Wroolie T.E. Topiramate: effects on cognition in patients with epilepsy, migraine headache and obesity. Ther Adv Neurol Disord 2013, 6:211-227.
43. Martin R., Kuzniecky R., Ho S., Hetherington H., Pan J., Sinclair K., et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999, 52:321-327.
44. Mula M., Hesdorffer D.C., Trimble M., Sander J.W. The role of titration schedule of topiramate for the development of depression in patients with epilepsy. Epilepsia 2009, 50:1072-1076.
45. Mula M., Trimble M.R., Lhatoo S.D., Sander J.W. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia 2003, 44:659-663.
46. Physicians' Desk Reference 2010, Thomson PDR, Montvale, NJ.
47. Torres A.R., Whitney J., Gonzalez-Heydrich J. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav 2008, 12:217-233.
48. Salpekar J., Dadson N. "Psychiatry and Epilepsy: A Century of Evolving Understanding" in Epilepsy: A Century of Discovery. 2012, 233-255. Nova Science Publishers, Inc., Hauppauge, New York. R. Bautista (Ed.).
49. Gucuyener K., Erdemoglu A.K., Senol S., Serdaroglu A., Soysal S., Kockar A.I. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities. J Child Neurol 2003, 18:109-112.
50. Wernicke J.F., Holdridge K.C., Jin L., Edison T., Zhang S., Bangs M.E., et al. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine. Dev Med Child Neurol 2007, 49:498-502.
51. Torres A., Whitney J., Rao S., Tilley C., Lobel R., Gonzalez-Heydrich J. Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy. Epilepsy Behav 2011, 20:95-102.
52. Santos K., Palmini A., Radziuk A.L., Rotert R., Bastos F., Booij L., et al. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies. Dev Med Child Neurol 2013, 55:654-660.
53. Gonzalez-Heydrich J., Whitney J., Waber D., Forbes P., Hsin O., Faraone S.V., et al. Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. Epilepsy Behav 2010, 18:229-237.
54. Holtmann M., Matei A., Hellmann U., Becker K., Poustka F., Schmidt M.H. Rolandic spikes increase impulsivity in ADHD - a neuropsychological pilot study. Brain Dev 2006, 28:633-640.
55. Pavuluri M.N., Yang S., Kamineni K., Passarotti A.M., Srinivasan G., Harral E.M., et al. Diffusion tensor imaging study of white matter fiber tracts in pediatric bipolar disorder and attention-deficit/hyperactivity disorder. Biol Psychiatry 2009, 65:586-593.
56. Seidman L.J., Valera E.M., Makris N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1263-1272.
57. Sprafkin J., Gadow K.D., Salisbury H., Schneider J., Loney J. Further evidence of reliability and validity of the Child Symptom Inventory-4: parent checklist in clinically referred boys. J Clin Child Adolesc Psychol 2002, 31:513-524.
58. Achenbach T.M., Rescorla L.A. Manual for ASEBA school-age forms & profiles 2001, University of Vermont, Research Center for Children, Youth, & Families, Burlington, VT.
59. Kirk J.W., Hutaff-Lee C.F., Connery A.K., Baker D.A., Kirkwood M.W. The relationship between the self-report BASC-2 validity indicators and performance validity test failure after pediatric mild traumatic brain injury. Assessment February 14, 2014, 10.1177/1073191114520626.
60. Conners C.K., Sitarenios G., Parker J.D., Epstein J.N. Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 1998, 26:279-291.
61. Zhang S., Faries D.E., Vowles M., Michelson D. ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument. Int J Methods Psychiatr Res 2005, 14:186-201.
62. Wolraich M.L., Lambert W., Doffing M.A., Bickman L., Simmons T., Worley K. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol 2003, 28:559-567.
63. Swanson J.M., Kraemer H.C., Hinshaw S.P., Arnold L.E., Conners C.K., Abikoff H.B., et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 2001, 40:168-179.
64. Jones J.E., Austin J.K., Caplan R., Dunn D., Plioplys S., Salpekar J.A. Psychiatric disorders in children and adolescents who have epilepsy. Pediatr Rev 2008, 29:e9-e14.
65. Feldman H., Crumrine P., Handen B.L., Alvin R., Teodori J. Methylphenidate in children with seizures and attention-deficit disorder. Am J Dis Child 1989, 143:1081-1086.
66. Gross-Tsur V., Manor O., van der Meere J., Joseph A., Shalev R.S. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?. J Pediatr 1997, 130:40-44.
67. Yoo H.K., Park S., Wang H.R., Lee J.S., Kim K., Paik K.W., et al. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system. Epileptic Disord 2009, 11:301-308.
68. Fosi T., Lax-Pericall M.T., Scott R.C., Neville B.G., Aylett S.E. Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit. Epilepsia Dec 2011, 54(12):2071-2081.
69. Wroblewski B.A., Guidos A., Leary J., Joseph A.B. Control of depression with fluoxetine and antiseizure medication in a brain-injured patient. Am J Psychiatry 1992, 149:273.